Companies / Parabilis Medicines, Inc.
Parabilis Medicines, Inc.
Nasdaq: PBLSCIK 1657677CAMBRIDGE, MA
Ownership
121.9M shares outstanding
Ownership
| Insiders | 2.29% | 2,798,380 |
| 10%+ / strategic | 1.54% | 1,880,704 |
| Institutions | 7.50% | 9,144,845 |
| Public float | 88.66% | 108,114,723 |
% of common shares outstanding (single-class filing figure). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.
Insiders 14
View all →| Insider | % of shares | Shares |
|---|---|---|
RA Capital Management, L.P.Director · 10% owner | 2.17% | 2,648,278 |
Deerfield Mgmt, L.P.10% owner | 1.54% | 1,880,704 |
Borisy AlexisDirector | 0.09% | 105,414 |
Sebulsky AlanDirector | 0.02% | 30,000 |
Fitzgerald Edward MDirector | 0.01% | 14,688 |
| — | — | |
Deerfield Management Company, L.P.10% owner | — | — |
Deerfield Mgmt HIF, L.P.10% owner | — | — |
Deerfield Mgmt III, L.P.10% owner | — | — |
| — | — |
Institutional holders 6
View all →| Holder | Value | % of shares |
|---|---|---|
| $134.65M | 4.03% | |
| $114.04M | 3.42% | |
| $955.2K | 0.03% | |
| $525.5K | 0.02% | |
| $113.0K | <0.01% | |
| $12.3K | <0.01% |
Activity
Jun 30, 2026View all →
InsidersInstitutions
Who's accumulating and trimming this stock (13F).| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Q2 2026 as of | Alphabet Inc. 13F manager | New | Common Stock | $134.65M | +4.9M | 4,919,498 4.03% of shares | high |
| Q2 2026 as of | Regeneron Pharmaceuticals, Inc. 13F manager | New | Common Stock | $114.04M | +4.2M | 4,166,666 3.42% of shares | high |
| Q2 2026 as of | WINTON GROUP Ltd 13F manager | New | Common Stock | $955.2K | +35K | 34,900 0.03% of shares | low |
| Q2 2026 as of | Mitsubishi UFJ Asset Management Co., Ltd. 13F manager | New | Common Stock | $525.5K | +19K | 19,200 0.02% of shares | low |
| Q2 2026 as of | Persistent Asset Partners Ltd 13F manager | New | Common Stock | $113.0K | +4K | 4,130 <0.01% of shares | low |
| Q2 2026 as of | Bell Investment Advisors, Inc 13F manager | New | Common Stock | $12.3K | +451 | 451 <0.01% of shares | low |
Securities
via CUSIP / OpenFIGI
| Symbol | Type | CUSIP |
|---|---|---|
| PBLS | Common Stock | 698955101 |